These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8444058)

  • 21. MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration.
    Kállai A; Kelemen M; Molnár N; Tropotei A; Hauser B; Iványi Z; Gál J; Ligeti E; Kristóf K; Lőrincz ÁM
    Microbiol Spectr; 2021 Dec; 9(3):e0090121. PubMed ID: 34878335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-antibiotic effect and killing activity of ciprofloxacin against Staphylococcus aureus.
    Fuursted K
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):199-202. PubMed ID: 3630713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-antibiotic effect of the new streptogramin RP 59500.
    Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
    Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
    Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
    Haukland HH; Vorland LH
    J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of bacterial combinations on the post-antibiotic effect].
    Mínguez F; Aparicio P; Lurueña S; Cabronero MJ; Prieto J
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):208-12. PubMed ID: 2090206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae.
    Lemmen SW; Häfner H; Klik S; Lütticken R; Zolldann D
    Chemotherapy; 2003 May; 49(1-2):33-5. PubMed ID: 12714807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
    Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of inhibitors of bacterial cell wall biogenesis. Analogs of D-alanyl-D-alanine.
    Smissman EE; Terada A; El-Antably S
    J Med Chem; 1976 Jan; 19(1):165-7. PubMed ID: 812991
    [No Abstract]   [Full Text] [Related]  

  • 32. Outer membrane proteins of Klebsiella pneumoniae after exposure to ciprofloxacin.
    Hostacká A; Karelová E
    Zentralbl Bakteriol; 1998 May; 287(4):343-6. PubMed ID: 9638864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The postantibiotic effect of fusidic acid against gram-positive bacteria.
    Munckhof WJ; Turnidge JD
    J Antimicrob Chemother; 1997 Sep; 40(3):433-6. PubMed ID: 9338499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
    Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
    Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
    Andreoni O
    Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
    Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit AC; Schmitz FJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):938-42. PubMed ID: 11181385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the in vitro susceptibility and emergence of mutants resistant to ciprofloxacin among multidrug resistant clinical isolates.
    Lopes CA; Mendes RP; Curi PC; Watanabe DS; Decarlis RM; Horácio A; Michelin LA; Placidelli BA
    Rev Latinoam Microbiol; 1993; 35(4):345-9. PubMed ID: 8066328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of extracts of algae from Baja California sur, Mexico as reversers of the antibiotic resistance of some pathogenic bacteria.
    Muñoz-Ochoa M; Murillo-Alvarez JI; Zermeño-Cervantes LA; Martínez-Diaz S; Rodríguez-Riosmena R
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):739-47. PubMed ID: 21061832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.